← peptides typeshit

Mounjaro made $22.9b in 2025, second only to Keytruda, per Kanyi Maqubela

Maqubela's list of 2025 brand revenues puts Ozempic third at $19.2b, ahead of Dupixent and Skyrizi.

See it on X

Recap by typeshit. Post by Kanyi Maqubela on X.